Victrex plc (OTCMKTS:VTXPF) has been given an average rating of “Hold” by the eleven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating on the company.
A number of equities research analysts recently commented on the stock. Credit Suisse Group reissued an “outperform” rating on shares of Victrex in a research report on Wednesday, October 7th. Berenberg Bank reaffirmed a “hold” rating on shares of Victrex in a report on Tuesday, December 15th. Zacks Investment Research cut shares of Victrex from a “hold” rating to a “sell” rating in a report on Tuesday, December 1st. CSFB reaffirmed an “outperform” rating on shares of Victrex in a report on Wednesday, October 7th. Finally, Barclays raised shares of Victrex from an “underweight” rating to an “equal weight” rating in a report on Thursday, December 10th.
Victrex has a 52-week low of $21.82 and a 52-week high of $32.40. The company’s 50 day moving average price is $28.57 and its 200 day moving average price is $25.88. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.40 and a quick ratio of 2.40. The stock has a market capitalization of $2.69 billion, a PE ratio of 22.82 and a beta of 1.37.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It offers PEEK and PAEK polymer materials; and specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.